Reporting owner · CIK 0001643746
Kim Lorence H.
SEC Form 4 history across 1 companies, 14 transactions and 2 filings.
DIRRevolution Medicines, Inc.
Open-market transaction mix0% buys0 buys · 14 sales
Available history · Aug 31, 2026 – Sep 08, 2026
Latest insider transactions
Form 4 filings from available history.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
RVMDRevolution Medicines, Inc. | Kim Lorence H.DIR | S · sale10b5-1 detectedSEC filing ↗ | -$78.7kView disclosure → | |
RVMDRevolution Medicines, Inc. | Kim Lorence H.DIR | S · sale10b5-1 detectedSEC filing ↗ | -$812kView disclosure → | |
RVMDRevolution Medicines, Inc. | Kim Lorence H.DIR | S · sale10b5-1 detectedSEC filing ↗ | -$995kView disclosure → | |
RVMDRevolution Medicines, Inc. | Kim Lorence H.DIR | S · sale10b5-1 detectedSEC filing ↗ | -$597kView disclosure → | |
RVMDRevolution Medicines, Inc. | Kim Lorence H.DIR | S · sale10b5-1 detectedSEC filing ↗ | -$748kView disclosure → | |
RVMDRevolution Medicines, Inc. | Kim Lorence H.DIR | S · sale10b5-1 detectedSEC filing ↗ | -$207kView disclosure → | |
RVMDRevolution Medicines, Inc. | Kim Lorence H.DIR | S · sale10b5-1 detectedSEC filing ↗ | -$145kView disclosure → | |
RVMDRevolution Medicines, Inc. | Kim Lorence H.DIR | S · sale10b5-1 detectedSEC filing ↗ | -$128kView disclosure → | |
RVMDRevolution Medicines, Inc. | Kim Lorence H.DIR | S · sale10b5-1 detectedSEC filing ↗ | -$436kView disclosure → | |
RVMDRevolution Medicines, Inc. | Kim Lorence H.DIR | S · sale10b5-1 detectedSEC filing ↗ | -$1.48MView disclosure → | |
RVMDRevolution Medicines, Inc. | Kim Lorence H.DIR | S · sale10b5-1 detectedSEC filing ↗ | -$5.32MView disclosure → | |
RVMDRevolution Medicines, Inc. | Kim Lorence H.DIR | S · sale10b5-1 detectedSEC filing ↗ | -$2.61MView disclosure → | |
RVMDRevolution Medicines, Inc. | Kim Lorence H.DIR | S · sale10b5-1 detectedSEC filing ↗ | -$1.32MView disclosure → | |
RVMDRevolution Medicines, Inc. | Kim Lorence H.DIR | S · sale10b5-1 detectedSEC filing ↗ | -$60.1kView disclosure → |
Latest Form 4 facts
Quick context from source filings
Latest open-market transaction
sale at Revolution Medicines, Inc. on Sep 08, 2026 valued at $78,752.
Review SEC filingLatest buy
No open-market insider purchase is available.
Monthly open-market activity
Last 2 reported months · purchases and sales
View exact monthly values
| Month | Purchases | Sales | Buy value | Sale value | Net value |
|---|---|---|---|---|---|
| Aug 2026 | 0 | 7 | $0.00 | $11,381,287.60 | -$11,381,287.60 |
| Sep 2026 | 0 | 7 | $0.00 | $3,585,836.94 | -$3,585,836.94 |
Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.
Ownership and transaction size
Ownership and ticket size
Average P/S size$1.1M
Median P/S size$673K
Direct0
Indirect14
Sep 08, 2026sale
Filing-only signals
Deterministic matches in this insider's history
No filing-only signal badges matched this history.
Associated companies
Companies in the disclosed reporting history
Open-market buy performance
90-day forward return on this insider's open-market purchases
No open-market purchases in available history
A 90-day purchase return requires an open-market buy. No eligible purchases are recorded in this history.
Disclosed ownership
How reported shareholdings evolved
Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.
14 observations · Aug 31, 2026 – Sep 8, 2026. Window ends at the latest available report, not today.
Selected observation · Sep 8, 20260 shares reported
Inspect transaction View exact observations and source transactions
| Transaction date | Shares held after | Filed | Source |
|---|---|---|---|
| Aug 31, 2026 | 72,790 | Sep 2, 2026 | View transaction |
| Aug 31, 2026 | 66,193 | Sep 2, 2026 | View transaction |
| Aug 31, 2026 | 53,274 | Sep 2, 2026 | View transaction |
| Aug 31, 2026 | 27,114 | Sep 2, 2026 | View transaction |
| Aug 31, 2026 | 19,843 | Sep 2, 2026 | View transaction |
| Aug 31, 2026 | 17,715 | Sep 2, 2026 | View transaction |
| Aug 31, 2026 | 17,090 | Sep 2, 2026 | View transaction |
| Sep 8, 2026 | 16,384 | Sep 10, 2026 | View transaction |
| Sep 8, 2026 | 15,385 | Sep 10, 2026 | View transaction |
| Sep 8, 2026 | 11,798 | Sep 10, 2026 | View transaction |
| Sep 8, 2026 | 8,945 | Sep 10, 2026 | View transaction |
| Sep 8, 2026 | 4,215 | Sep 10, 2026 | View transaction |
| Sep 8, 2026 | 371 | Sep 10, 2026 | View transaction |
| Sep 8, 2026 | 0 | Sep 10, 2026 | View transaction |
Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.
Kim Lorence H. Insider Activity FAQ
SEC Form 4 context
Who is Kim Lorence H.?
Kim Lorence H. is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001643746.
Which companies has Kim Lorence H. reported transactions for?
Revolution Medicines, Inc., Cencora, Inc.
When was Kim Lorence H.'s latest insider buy?
No open-market insider purchase is available for this period.
When was Kim Lorence H.'s latest insider sale?
sale at Revolution Medicines, Inc. on Sep 08, 2026 valued at $78,752.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.